HHM Wealth Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.6K Hold
881
– – ﹤0.01% 428
2026
Q1
$55.3K Hold
881
– – 0.01% 356
2025
Q4
$84K Hold
881
– – 0.01% 292
2025
Q3
$86K Hold
881
– – 0.01% 296
2025
Q2
$94.6K Hold
881
– – 0.01% 282
2025
Q1
$88.9K Buy
881
+103
+13% +$10.4K 0.01% 277
2024
Q4
$69.5K Buy
778
+54
+7% +$4.75K 0.01% 306
2024
Q3
$60.7K Buy
724
+708
+4,425% +$55.8K 0.01% 309
2024
Q2
$1.23K Buy
+16
New +$1.17K ﹤0.01% 725

Other funds holding BSX

HHM Wealth Advisors's BSX Position: Q2 2026 in Review

HHM Wealth Advisors held its Boston Scientific (BSX) position steady in Q2 2026 at 881 shares worth $37.6K. The position accounts for ﹤0.01% of the portfolio, ranked #428.

HHM Wealth Advisors first reported a position in BSX in Q2 2024 and has held it in 9 quarters since. The position peaked at $94.6K in Q2 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • HHM Wealth Advisors held 881 shares of Boston Scientific worth $37.6K as of Q2 2026.
  • HHM Wealth Advisors left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up ﹤0.01% of HHM Wealth Advisors's portfolio in Q2 2026, its #428 holding.
  • HHM Wealth Advisors first reported a position in Boston Scientific in Q2 2024 and has held it in 9 quarters since.
  • HHM Wealth Advisors's Boston Scientific position peaked at $94.6K in Q2 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.